Capr stock price forecast technical chart setups for the "capr

Technical chart setups for the "capr stock price forecast" show converging support and resistance zones, often preceding significant directional moves. Overview: Capricor Therapeutics, Inc. is a clinical-stage biotechnology company that develops cell and exosome-based therapeutics for treating Duchenne muscular dystrophy and other diseases with unmet medical needs, with a market cap of $725.25 million. Capricor Therapeutics will release its Q2 2025 financial results on August 13, 2025, after market close. Recent volatility patterns show the "capr stock price forecast" holding support near $5.80; any breach could trigger stop-loss selling, so risk management is key for swing traders.